Low nNOS protein in the locus coeraleus in major depression

Journal of Neurochemistry

Volumn 91, Issue 5, 2004, Pages 1057-1066

  Karolewicz, B ^a   Szebeni, K ^a   Stockmeier, C A ^a,b   Konick, L ^b   Overholser, J C ^b   Jurjus, G ^b   Roth, B L ^b   Ordway, G A ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Cerebellum; Locus coeruleus; Major depression; Neuronal nitric oxide synthase

Indexed keywords

GLUTAMATE RECEPTOR; NEUROMELANIN; NITRIC OXIDE SYNTHASE;

ARTICLE; BRAIN NERVE CELL; BRAIN REGION; BRAIN TISSUE; CEREBELLUM CORTEX; COMPARATIVE STUDY; CONTROLLED STUDY; GLIA CELL; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; LOCUS CERULEUS; MAJOR DEPRESSION; NERVE CELL EXCITABILITY; NEUROPATHOLOGY; PH MEASUREMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN LOCALIZATION; RECEPTOR INTRINSIC ACTIVITY;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CEREBELLUM; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; IMMUNOHISTOCHEMISTRY; LOCUS COERULEUS; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE I; POSTMORTEM CHANGES; TIME FACTORS;

EID: 9744273098     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2004.02792.x     Document Type: Article

References (64)

1. Allgaier C., Durmaz M., Muller D., Franke H., Poelchen W., Wirkner K. and Illes P. (2001) Single-cell RT-PCR analysis of N-methyl-D-aspartate receptor subunit expression in rat locus coeruleus neurones. Naunyn Schmiedebergs Arch. Pharmacol. 363, 120-123.
2. Altamura C. A., Mauri M. C., Ferrara A., Moro A. R., D'Andrea G. and Zamberlan F. (1993) Plasma and platelet excitatory amino acids in psychiatric disorders. Am. J. Psychiatry 150, 1731-1733.
3. Altamura C., Maes M., Dai J. and Meltzer H. Y. (1995) Plasma concentrations of excitatory amino acids, serine, glycine, taurine and histidine in major depression. Eur. Neuropsychopharmacol. 5, 71-75.
4. Aoki E., Semba R., Mikoshiba K. and Kashiwamata S. (1991) Predominant localization in glial cells of free 1-arginine: immunocytochemical evidence. Brain Res. 547, 190-192.
5. Arbones M. L., Ribera J., Agullo L., Baltrons M. A., Casanovas A., Riveros-Moreno V. and Garcia A. (1996) Characteristics of nitric oxide synthase type I of rat cerebellar astrocytes. Glia 18, 224-232.
6. Aston-Jones G., Shipley M. T., Chouvet G. et al. (1991) Afferent regulation of locus coeruleus neurons: anatomy, physiology and pharmacology. Prog. Brain Res. 88, 47-75.
7. Baltrons M. A. and Garcia A. (1997) AMPA receptors are coupled to the nitric oxide/cyclic GMP pathway in cerebellar astroglial cells. Eur. J. Neurosci. 9, 2497-2501.
8. Benavides-Piccione R. and DeFelipe J. (2003) Different populations of tyrosine-hydroxylase-immunoreactive neurons defined by differential expression of nitric oxide synthase in the human temporal cortex. Cereb. Cortex 13, 297-307.
9. Berman R. M., Cappiello A., Anand A., Oren D. A., Heninger G. R., Charney D. S. and Krystal J. H. (2000) Antidepressant effects of ketamine in depressed patients. Biol. Psychiatry 47, 351-354.
10. Bernstein H. G., Stanarius A., Baumann B., Henning H., Krell D., Danos P., Falkai P. and Bogerts B. (1998) Nitric oxide synthase-containing neurons in the human hypothalamus: reduced number of immunoreactive cells in the paraventricular nucleus of depressive patients and schizophrenics. Neuroscience 83, 867-875.
11. Bernstein H. G., Heinemann A., Krell D., Mawrin C., Bielau H., Danos P., Diekmann S., Keilhoff G., Bogerts B. and Baumann B. (2002) Further immunohistochemical evidence for impaired NO signaling in the hypothalamus of depressed patients. Ann. N Y Acad. Sci. 973, 91-93.
12. Boissel J. P., Schwarz P. M. and Forstermann U. (1998) Neuronal-type NO synthase: transcript diversity and expressional regulation. Nitric Oxide 2, 337-349.
13. Bowley M. P., Drevets W. C., Ongur D. and Price J. L. (2002) Low glial numbers in the amygdala in major depressive disorder. Biol. Psychiatry 52, 404-412.
14. Bredt D. S. and Snyder S. H. (1989) Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc. Natl Acad. Sci. USA 86, 9030-9033.
15. Bredt D. S., Glatt C. E., Hwang P. M., Fotuhi M., Dawson T. M. and Snyder S. H. (1991) Nitric oxide synthase protein and mRNA are discretely localized in neuronal populations of the mammalian CNS together with NADPH diaphorase. Neuron 7, 615-624.
16. Choi D. W. and Hartley D. M. (1993) Calcium and glutamate-induced cortical neuronal death. Res. Pub. Assoc. Res. Nerv Ment Dis. 71, 23-34.
17. Corder R., Pralong F. P., Muller A. F. and Gaillard R. C. (1990) Regional distribution of neuropeptide Y-like immunoreactivity in human hypothalamus measured by immunoradiometric assay: possible influence of chronic respiratory failure on tissue levels. Neuroendocrinology 51, 23-30.
18. Cotter D., Mackay D., Landau S., Kerwin R. and Everall I. (2001) Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. Arch. Gen. Psychiatry 58, 545-553.
19. Cotter D., Mackay D., Chana G., Beasley C., Landau S. and Everall I. P. (2002) Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder. Cereb. Cortex 12, 386-394.
20. Cuellar B., Fernandez A. P., Lizasoain I., Moro M. A., Lorenzo P., Bentura M. L., Rodrigo J. and Leza J. C. (2000) Up-regulation of neuronal NO synthase immunoreactivity in opiate dependence and withdrawal. Psychopharmacology (Berl.) 148, 66-73.
21. Dawson V. L., Dawson T. M., London E. D., Bredt D. S. and Snyder S. H. (1991) Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc. Natl Acad. Sci. USA 88, 6368-6371.
22. Do K. Q., Grima G., Benz B. and Salt T. E. (2002) Glial-neuronal transfer of arginine and S-nitrosothiols in nitric oxide transmission. Ann. N Y Acad. Sci. 962, 81-92.
23. First M. B., Donovan S. and Frances A. (1996) Nosology of chronic mood disorders. Psychiatr Clin. N. Am. 19, 29-39.
24. Garthwaite J., Charles S. L. and Chess-Williams R. (1988) Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature 336, 385-388.
25. Garthwaite J., Garthwaite G., Palmer R. M. and Moncada S. (1989) NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices. Eur. J. Pharmacol. 172, 413-416.
26. Gerlach M., Blum-Degen D., Ransmayr G., Leblhuber F., Pedersen V. and Riederer P. (2001) Expression, but not activity, of neuronal nitric oxide synthase is regionally increased in the alcoholic brain. Alcohol Alcohol 36, 65-69.
27. Grima G., Benz B. and Do K. Q. (1997) Glutamate-induced release of the nitric oxide precursor, arginine, from glial cells. Eur. J. Neurosci. 9, 2248-2258.
28. Harkin A. J., Bruce K. H., Craft B. and Paul I. A. (1999) Nitric oxide synthase inhibitors have antidepressant-like properties in mice. 1. Acute treatments are active in the forced swim test. Eur. J. Pharmacol. 372, 207-213.
29. Harrison P. J., Procter A. W., Barton A. J., Lowe S. L., Najlerahim A., Bertolucci P. H., Bowen D. M. and Pearson R. C. (1991) Terminal coma affects messenger RNA detection in post mortem human temporal cortex. Brain Res. Mol. Brain Res. 9, 161-164.
30. Harrison P. J., Heath P. R., Eastwood S. L., Burnet P. W., McDonald B. and Pearson R. C. (1995) The relative importance of premortem acidosis and post mortem interval for human brain gene expression studies: selective mRNA vulnerability and comparison with their encoded proteins. Neurosci. Lett. 200, 151-154.
31. Karolewicz B., Bruce K. H., Lee B. and Paul I. A. (1999) Nitric oxide synthase inhibitors have antidepressant-like properties in mice. 2. Chronic treatment results in downregulation of cortical beta-adrenoceptors. Eur. J. Pharmacol. 372, 215-220.
32. Karolewicz B., Paul I. A. and Antkiewicz-Michaluk L. (2001) Effect of NOS inhibitor on forced swim test and neurotransmitters turnover in the mouse brain. Pol. J. Pharmacol. 53, 587-596.
33. Kim J. S., Schmid-Burgk W., Claus D. and Kornhuber H. H. (1982) Increased serum glutamate in depressed patients. Arch. Psychiatr Nervenkr. 232, 299-304.
34. Kingsbury A. E., Foster O. J., Nisbet A. P., Cairns N., Bray L., Eve D. J., Lees A. J. and Marsden C. D. (1995) Tissue pH as an indicator of mRNA preservation in human post-mortem brain. Brain Res. Mol. Brain Res. 28, 311-318.
35. Klimek V., Stockmeier C., Overholser J., Meltzer H. Y., Kalka S., Dilley G. and Ordway G. A. (1997) Reduced levels of norepinephrine transporters in the locus coeruleus in major depression. J. Neurosci. 17, 8451-8458.
36. Kugler P. and Drenckhahn D. (1996) Astrocytes and Bergmann glia as an important site of nitric oxide synthase I. Glia 16, 165-173.
37. Layer R. T., Popik P., Olds T. and Skolnick P. (1995) Antidepressant-like actions of the polyamine site NMDA antagonist, eliprodil (SL-82.0715). Pharmacol. Biochem. Behav. 52, 621-627.
38. Levine J., Panchalingam K., Rapoport A., Gershon S., McClure R. J. and Pettegrew J. W. (2000) Increased cerebrospinal fluid glutamine levels in depressed patients. Biol. Psychiatry 47, 586-593.
39. Mauri M. C., Ferrara A., Boscati L., Bravin S., Zamberlan F., Alecci M. and Invernizzi G. (1998) Plasma and platelet amino acid concentrations in patients affected by major depression and under fluvoxamine treatment. Neuropsychobiology 37, 124-129.
40. Moryl E., Danysz W. and Quack G. (1993) Potential antidepressive properties of amantadine, memantine and bifemelane. Pharmacol. Toxicol. 72, 394-397.
41. Ongur D., Drevets W. C. and Price J. L. (1998) Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc. Natl Acad. Sci. USA 95, 13290-13295.
42. Ordway G. A., Smith K. S. and Haycock J. W. (1994a) Elevated tyrosine hydroxylase in the locus coeruleus of suicide victims. J. Neurochem. 62, 680-685.
43. Ordway G. A., Widdowson P. S., Smith K. S. and Halaris A. (1994b) Agonist binding to alpha 2-adrenoceptors is elevated in the locus coeruleus from victims of suicide. J. Neurochem. 63, 617-624.
44. Ordway G. A., Klimek V. and Mann J. J. (2002) Neurocircuitry of mood disorders, in Neuropsychopharmacology: the Fith Generation of Progress. (Davis, K. L., Charney, D., Coyle, J. T. and Nemeroff, C., eds), pp. 1051-1064. Lippincott Williams & Wilkins, Philadelphia.
45. Ordway G. A., Schenk J., Stockmeier C. A., May W. and Klimek V. (2003) Elevated agonist binding to alpha(2)-adrenoceptors in the locus coeruleus in major depression. Biol. Psychiatry 53, 315-323.
46. Papp M. and Moryl E. (1994) Antidepressant activity of non-competitive and competitive NMDA receptor antagonists in a chronic mild stress model of depression. Eur. J. Pharmacol. 263, 1-7.
47. Perry E. K., Perry R. H. and Tomlinson B. E. (1982) The influence of agonal status on some neurochemical activities of post mortem human brain tissue. Neurosci. Lett. 29, 303-307.
48. Rajkowska G. (2000) Post mortem studies in mood disorders indicate altered numbers of neurons and glial cells. Biol. Psychiatry 48, 766-777.
49. Rajkowska G., Miguel-Hidalgo J. J., Wei J., Dilley G., Pittman S. D., Meltzer H. Y., Overholser J. C., Roth B. L. and Stockmeier C. A. (1999) Morphometric evidence for neuronal and glial preftontal cell pathology in major depression. Biol. Psychiatry 45, 1085-1098.
50. Schuman E. M. and Madison D. V. (1991) A requirement for the intercellular messenger nitric oxide in long-term potentiation. Science 254, 1503-1506.
51. 3H]MK-801 binding sites in the normal human brainstem in relation to motor neuron disease. Brain Res. 572, 276-280.
52. Simonian S. X. and Herbison A. E. (1996) Localization of neuronal nitric oxide synthase-immunoreactivity within sub-populations of noradrenergic A1 and A2 neurons in the rat. Brain Res. 732, 247-252.
53. Skolnick P. (1999) Antidepressants for the new millennium. Eur. J. Pharmacol. 375, 31-40.
54. Tomita H., Vawter M. P., Walsh D. M. et al. (2004) Effect of agonal and post mortem factors on gene expression profile: quality control in microarray analyses of post mortem human brain. Biol. Psychiatry 55, 346-352.
55. Van Bockstaele E. J. and Colago E. E. (1996) Selective distribution of the NMDA-R1 glutamate receptor in astrocytes and presynaptic axon terminals in the nucleus locus coeruleus of the rat brain: an immunoelectron microscopic study. J. Comp. Neurol. 369, 483-496.
56. Volke V., Wegener G., Bourin M. and Vasar E. (2003) Antidepressant-and anxiolytic-like effects of selective neuronal NOS inhibitor 1-(2- trifluoromethylphenyl)-imidazole in mice. Behav. Brain Res. 140, 141-147.
57. Vulliemoz Y., Whittington R. A. and Virag L. (1999) The nitric oxide-cGMP system of the locus coeruleus and the hypnotic action of alpha-2 adrenergic agonists. Brain Res. 849, 169-174.
58. Wang Y., Newton D. C. and Marsden P. A. (1999) Neuronal NOS: gene structure, mRNA diversity, and functional relevance. Crit. Rev. Neurobiol. 13, 21-43.
59. Xing G., Chavko M., Zhang L. X., Yang S. and Post R. M. (2002) Decreased calcium-dependent constitutive nitric oxide synthase (cNOS) activity in prefrontal cortex in schizophrenia and depression. Schizophr. Res. 58, 21-30.
60. Xu Z. Q., Pieribone V. A., Zhang X., Grillner S. and Hokfelt T. (1994) A functional role for nitric oxide in locus coeruleus: immunohistochemical and electrophysiological studies. Exp. Brain Res. 98, 75-83.
61. Xu Z. Q., de Vente J., Steinbusch H., Grillner S. and Hokfelt T. (1998) The NO-cGMP pathway in the rat locus coeruleus: electrophysiological, immunohistochemical and in situ hybridization studies. Eur. J. Neurosci. 10, 3508-3516.
62. Yates C. M., Butterworth J., Tennant M. C. and Gordon A. (1990) Enzyme activities in relation to pH and lactate in post mortem brain in Alzheimer-type and other dementias. J. Neurochem. 55, 1624-1630.
63. Yildiz F., Erden B. F., Ulak G., Utkan T. and Gacar N. (2000) Antidepressant-like effect of 7-nitroindazole in the forced swimming test in rats. Psychopharmacology (Berl.) 149, 41-44.
64. Zhu M. Y., Klimek V., Dilley G. E., Haycock J. W., Stockmeier C., Overholser J. C., Meltzer H. Y. and Ordway G. A. (1999) Elevated levels of tyrosine hydroxylase in the locus coeruleus in major depression. Biol. Psychiatry 46, 1275-1286.